Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

NCT00581607 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Sarcoidosis
Pulmonary Arterial Hypertension

Interventions

DRUG: Bosentan
DRUG: Placebo
DRUG: Bosentan
DRUG: Placebo

Sponsor

University of Cincinnati

Collaborators

[object Object]